Hrs [IST] The World Health Organisation has recently released the ‘WHO 2025 Global Antibiotic Resista ...
"GC [gonococcal] AMR [antimicrobial resistance] is of concern worldwide, particularly resistance to third-generation cephalosporins and fluoroquinolones, and is considered a priority issue by the WHO ...
NEW YORK — Researchers on Wednesday reported two promising new approaches to counteract malaria’s growing resistance to ...
The Lundquist Institute (TLI) and its start-up company Vitalex Biosciences (Vitalex) are pleased to announce that the second-generation fungal vaccine candidate known as VXV--01, which was developed ...
The James Webb Space Telescope may have discovered Population III stars, the universe's first generation of stars. They may ...
The contract, awarded by NIH/NIAID, provides up to US $40 million of non-dilutive funding to Vitalex and its collaborator Appili and for the comprehensive development of VXV-01.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback